Hardik Parikh
Stock Analyst at J.P. Morgan
(0.60)
# 4,184
Out of 4,639 analysts
27
Total ratings
30.8%
Success rate
-6.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Maintained: Buy | $75 → $65 | $34.44 | +88.73% | 8 | Aug 11, 2026 | |
| PCRX Pacira BioSciences | Maintained: Sell | $23 | $24.43 | -5.85% | 12 | Aug 10, 2026 | |
| GPCR Structure Therapeutics | Maintained: Buy | n/a | $53.81 | - | 6 | Jun 9, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | $30 | $18.98 | +58.06% | 1 | May 12, 2026 |
Viking Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $75 → $65
Current: $34.44
Upside: +88.73%
Pacira BioSciences
Aug 10, 2026
Maintained: Sell
Price Target: $23
Current: $24.43
Upside: -5.85%
Structure Therapeutics
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $53.81
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $18.98
Upside: +58.06%